Two stakeholders make suggestions for revising the FDA software precertification working model.
The Justice Department says Covidien is paying more than $17 million in settle False Claims Act whistleblower allegations that it illegally provided s...
FDA releases its latest batch of Warning Letters that include Anicare Pharmaceutical, Jubilant Life Sciences, Laboratorios Quantium and Pfizer (Hospir...
FDA approves an Alkem Laboratories ANDA for a new generic of Diovan (valsartan), an angiotensin II receptor blocker that treats high blood pressure an...
FDA releases the FDA-483 with two observations from an inspection at Indias Biocon Limited.
FDA qualifies a software module to help develop medical devices to treat traumatic brain injury.
FDA approves Regeneron Pharmaceuticals Dupixent (dupilumab) for adolescent patients 12 to 17 years of age with moderate-to-severe atopic dermatitis wh...